Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Kardiol Pol ; 65(11): 1363-6; discussion 1366-7, 2007 Nov.
Article in Polish | MEDLINE | ID: mdl-18058587

ABSTRACT

A case of a 26-year-old patient with acute myocardial infarction and hypertension, hyperlipidaemia as well as type 1 diabetes from 18 years complicated by background retinopathy and nephropathy in the state of proteinuria is described. State of metabolic compensation of the diabetes was poor. The patient did not perform regular self-monitoring of glycaemia, smoked, and used oral contraception. Early diagnosis of vascular lesions in young persons with long-lasting of type 1 diabetes as well as the introduction of proper preventive and treatment methods may improve prognosis in these high-risk patients.


Subject(s)
Diabetes Mellitus, Type 1/complications , Myocardial Infarction/etiology , Adult , Diabetic Nephropathies/etiology , Diabetic Retinopathy/etiology , Female , Humans , Hyperlipidemias/complications , Hypertension/complications , Risk Factors
3.
Pol Arch Med Wewn ; 117(3): 43-8, 2007 Mar.
Article in Polish | MEDLINE | ID: mdl-17718052

ABSTRACT

Cardiovascular complications are the leading cause of increasing and premature mortality in diabetic patients. Matrix metalloproteinases (MMPs) play an important role in the development and progression of vascular lesions. Matrix metalloproteinases are members of endopeptidases and are capable of degrading many extracellular matrix components. Results of recent studies indicated that non-pharmacological and pharmacological treatment of diabetes influenced disturbed system of metalloproteinases and their inhibitors. Clinical trials are being performed in hope that the selective MMP inhibitors reduce the progression of pathological vascular remodeling in diabetes. Further basic and clinical research is required to confirm hypothesis.


Subject(s)
Diabetic Angiopathies/enzymology , Matrix Metalloproteinases/physiology , Cardiovascular Diseases/enzymology , Cardiovascular Diseases/physiopathology , Clinical Trials as Topic , Diabetic Angiopathies/physiopathology , Humans , Matrix Metalloproteinase Inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL
...